197 related articles for article (PubMed ID: 16642562)
1. Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review.
Park SG; Chang JY; Cho YH; Kim SC; Lee MG
Yonsei Med J; 2006 Apr; 47(2):278-81. PubMed ID: 16642562
[TBL] [Abstract][Full Text] [Related]
2. Clinical and immunological profile of umbilical involvement in pemphigus vulgaris and pemphigus foliaceus.
Oliveira Júnior JV; Maruta CW; Sousa JX; Santi CG; Valente NY; Ichimura LM; Périgo AM; Aoki V
Clin Exp Dermatol; 2013 Jan; 38(1):20-4. PubMed ID: 23083306
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing Pemphigus foliaceus: a retrospective analysis of clinical, histological and immunological criteria.
Delmonte S; Kanitakis J; Cozzani E; Parodi A; Rebora A
Dermatology; 2001; 203(4):289-93. PubMed ID: 11752814
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
[TBL] [Abstract][Full Text] [Related]
5. [Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].
Lévy-Sitbon C; Reguiaï Z; Durlach A; Goeldel AL; Grange F; Bernard P
Ann Dermatol Venereol; 2013 Dec; 140(12):788-92. PubMed ID: 24315225
[TBL] [Abstract][Full Text] [Related]
6. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
[TBL] [Abstract][Full Text] [Related]
7. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
[TBL] [Abstract][Full Text] [Related]
8. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus with features of both vulgaris and foliaceus variants localized to the nose.
Mandel VD; Farnetani F; Vaschieri C; Manfredini M; Cesinaro AM; Giusti F; Pellacani G
J Dermatol; 2016 Aug; 43(8):940-3. PubMed ID: 26945696
[TBL] [Abstract][Full Text] [Related]
10. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
[TBL] [Abstract][Full Text] [Related]
11. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects and immunopathology in 48 patients with pemphigus].
Hahn K; Kippes W; Amagai M; Rzany B; Bröcker EB; Zillikens D
Hautarzt; 2000 Sep; 51(9):670-7. PubMed ID: 11057394
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus Vegetans of Hallopeau: A Case Report.
Maljić J; Radoš J; Lončarić D; Lakoš Jukić I
Acta Dermatovenerol Croat; 2023 Aug; 31(1):43-44. PubMed ID: 37843091
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
Carew B; Wagner G
Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
[TBL] [Abstract][Full Text] [Related]
17. Is transition between subtypes of pemphigus possible? A series of pemphigus vulgaris patients showing the transition to pemphigus foliaceus.
Kucukoglu R; Atci T; Sun GP
An Bras Dermatol; 2023; 98(6):787-792. PubMed ID: 37357115
[TBL] [Abstract][Full Text] [Related]
18. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.
Ohata C; Ishii N; Furumura M
J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985
[TBL] [Abstract][Full Text] [Related]
19. Case of pemphigus foliaceus that shifted into pemphigus vulgaris after adrenal tumor resection.
Awazawa R; Yamamoto Y; Gushi M; Taira K; Yagi N; Asato Y; Hagiwara K; Uezato H
J Dermatol; 2007 Aug; 34(8):549-55. PubMed ID: 17683386
[TBL] [Abstract][Full Text] [Related]
20. Pemphigus with features of both vulgaris and foliaceus variants, associated with antibodies to 160 and 130 kDa antigens.
Izumi T; Seishima M; Satoh S; Ito A; Kamiya H; Kitajima Y
Br J Dermatol; 1998 Oct; 139(4):688-92. PubMed ID: 9892915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
